Risk For Renal Damage Following Open Heart Surgery clinical trials

Explore recruiting risk for renal damage following open heart surgery clinical trials.

Also recruiting in Europe

Risk For Renal Damage Following Open Heart Surgery trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Ilofotase Alfa in Patients at Risk for Renal Damage Following Open Heart Surgery.

Germany, Belgium, Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Risk For Renal Damage Following Open Heart Surgery trials by city

Risk For Renal Damage Following Open Heart Surgery in Toronto Risk For Renal Damage Following Open Heart Surgery in Vancouver Risk For Renal Damage Following Open Heart Surgery in Montreal Risk For Renal Damage Following Open Heart Surgery in Calgary Risk For Renal Damage Following Open Heart Surgery in Edmonton Risk For Renal Damage Following Open Heart Surgery in Ottawa Risk For Renal Damage Following Open Heart Surgery in Winnipeg Risk For Renal Damage Following Open Heart Surgery in Quebec City Risk For Renal Damage Following Open Heart Surgery in Hamilton Risk For Renal Damage Following Open Heart Surgery in Kitchener Risk For Renal Damage Following Open Heart Surgery in London Risk For Renal Damage Following Open Heart Surgery in Halifax Risk For Renal Damage Following Open Heart Surgery in New York Risk For Renal Damage Following Open Heart Surgery in Los Angeles Risk For Renal Damage Following Open Heart Surgery in Chicago Risk For Renal Damage Following Open Heart Surgery in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease